Emily D. Gottfried, PhD, is an Associate Professor at the Medical University of South Carolina (MUSC) in the Department of Psychiatry and Behavioral Sciences, College of Medicine. She serves as Director of the MUSC Sexual Behaviors Clinic and Lab (SBCL) and CPSPD Student Education & Research, conducting forensic evaluations, physiological sexual arousal assessments, and mentoring students. She is licensed in South Carolina and Georgia, and a National Register Health Service Psychologist. Bachelor’s in Psychology, San Diego State University Master’s in Psychology, Teachers College, Columbia University PhD in Clinical Psychology, Florida State University Her research focuses on sex offender risk assessment , malingering detection (PPG/VPP technology), female offender psychology , and forensic evaluation validity . Recent work includes dimensional personality models and QAnon-related threat analysis . She has published extensively on psychopathy , penile/vaginal plethysmography , and mental health court outcomes . Notable publication trends include Forensic validity of symptom detection tools Psychopathy in female offenders Technology's role in sexual behavior assessment Telehealth adaptation during pandemics MMPI-2-RF applications in correctional settings Psychological factors in civil commitment She leads ongoing funded studies on female sexual arousal and police officer behavioral outcomes , operating at the intersection of forensic science and clinical psychology .
Professor David Alldred is a Professor of Medicines Use and Safety at the University of Leeds' School of Healthcare, within the Faculty of Medicine and Health. His expertise spans medicines optimisation, patient safety, deprescribing, and care home medication management. He leads key research initiatives such as the NIHR Yorkshire and Humber Patient Safety Research Collaboration's 'Decluttering Safely for Safety' theme and co-leads the School of Healthcare's Quality and Safety research theme. Education: PhD (clinical research on care home medication review), MSc in Clinical Pharmacy, PGCert in Learning and Teaching, and BPharm (Hons). Professional memberships include Fellowships of the Royal Pharmaceutical Society and the Higher Education Academy. Research focuses on improving medication use for older adults in care homes and underserved populations, employing systematic reviews, qualitative studies, and RCTs. Notable projects include the CHUMS study (Department of Health-funded medication error analysis in care homes) and leadership roles in NIHR Programme Grants like CHIPPS and CHARMER. He collaborates with NHS England to implement medicines optimisation programs and co-designed multilingual medication review resources to reduce health inequalities. Awards include the Pharmacy Practice UK Research Award (2015) and NIHR Senior Investigator status (2025). His work emphasizes translating evidence into clinical practice, with over 150 publications and supervising NIHR-funded doctoral students in critical care, diabetes, cystic fibrosis, and geriatrics. Led the Care Homes' Use of Medicines Study (CHUMS), contributed to NICE guidelines for care home medicines management, and developed interventions like the Medicines at Transitions Intervention (MaTI) for heart failure patients. His research themes address polypharmacy reduction, medication safety across care transitions, and pharmacist-led deprescribing strategies.
Vera Liao is a Principal Researcher at Microsoft Research, where she is part of the FATE (Fairness, Accountability, Transparency, and Ethics of AI) group. She will join the University of Michigan Computer Science and Engineering department as an Associate Professor in fall 2025. Her work focuses on human-AI interaction, explainable AI, and responsible computing. Liao has made significant contributions to IBM products such as AI Explainability 360 and Uncertainty Quantification 360 during her time at IBM T.J. Watson Research Center. Dr. Liao received her education from the University of Illinois at Urbana-Champaign and Tsinghua University. Her academic journey has positioned her at the intersection of human-computer interaction and artificial intelligence, with a strong emphasis on creating AI systems that are transparent, accountable, and user-centered. Vera Liao's research primarily centers around human-centered AI explainability and transparency. She investigates how to design AI systems that effectively communicate their capabilities, limitations, and decision-making processes to users. Her work examines the intersection of AI transparency with trust, control, and user experience. Liao has pioneered approaches to bridging the socio-technical gap in AI evaluation and has developed frameworks for contextualized evaluation of explainable AI systems. Her research spans multiple domains including conversational interfaces, data storytelling, and creative work with generative AI. Liao's publications reveal a clear trend toward addressing the challenges of large language models and their impact on human-AI interaction. Her recent work focuses on understanding how uncertainty communication affects user trust, how to design for appropriate reliance on AI systems, and how to create authentic co-creation experiences with generative models. She has been examining the risks in AI-infused information ecosystems and developing methods for human-centered evaluation of language technologies. Her scientific contributions have been recognized with multiple honors: Best Paper Award, Honorable Mention at CHI 2025 (two papers) Best Paper Award at CHI 2024 Best Paper Award, Honorable Mention at FAccT 2023 Best Paper Award, Honorable Mention at HCOMP 2022 Best Paper Award, Honorable Mention at CHI 2021 Best Paper Award, Honorable Mention at CHI 2014 Outstanding Paper Award at IUI 2019 Dr. Liao is an active mentor, having guided numerous research interns from top universities including Cornell, Princeton, CMU, Stanford, and MIT. She serves in editorial roles as Co-Editor-in-Chief of the Springer Human-Computer Interaction Book Series and as an Editor for ACM CSCW. Liao has secured research funding through her work at Microsoft Research and previously at IBM, focusing on projects related to AI explainability, transparency, and responsible AI development. As part of Microsoft Research's FATE group, Liao collaborates with a multidisciplinary team of researchers focused on the ethical implications of AI technologies. Her work bridges the gap between technical AI development and human-centered design principles, ensuring that AI systems are developed with user needs and societal impacts in mind.
Lena Wahlberg is an Associate Professor and Senior Lecturer at the Department of Law, Lund University, serving as Assistant Head of Department. Her roles include interdisciplinary research and teaching in medical law, evidence law, and jurisprudence. She leads the Law, Evidence and Cognition (LEVIC) research group and participates in the Science and Proven Experience (VBE) program funded by the Swedish Foundation for Humanities and Social Sciences. Her research focuses on legal causation, expert evidence evaluation, and the intersection of law with natural sciences/medicine. Notable projects include analyzing expert testimony reliability, legal implications of scientific evidence gaps, and defining 'science and proven experience' in healthcare decision-making. Recent publications (2024-2025) emphasize healthcare policy, data governance, and legislative reform in abortion laws and research ethics. She collaborates internationally with institutions like Harvard Medical School and Carnegie Mellon University. Teaching responsibilities include coordinating the doctoral course Theoretical Foundations for Doctoral Studies in Law . Supervised doctoral students include Amanda Bills (Public International Law) and Yana Litins’ka (Medical Law). Research funding includes projects from the Swedish Research Council and Riksbankens Jubilieumsfond. Key affiliations: Member of the VBE research consortium (2015-2020+), LEVIC group, and contributor to national policy consultations on health data and medical ethics.
Tara Garnett serves as Director of TABLE, a global knowledge platform for food systems analysis hosted by the Environmental Change Institute within the School of Geography and the Environment at the University of Oxford. TABLE operates as a collaboration between the University of Oxford, Wageningen University & Research, and the Swedish University of Agricultural Sciences, facilitating evidence-based dialogue on sustainable food futures. Her research interrogates the complex intersections between food systems, climate change, public health, and sustainability, with particular focus on livestock as a critical nexus point. Garnett investigates how scientific knowledge is translated across policy, civil society, and industry contexts, emphasizing the diverse values stakeholders bring to food system challenges. Her work consistently advocates for systems-thinking approaches that recognize the interconnected nature of food-related problems. As a fellow of the Oxford Martin School and co-investigator on the Wellcome Trust-funded Livestock, Environment and People (LEAP) project, she contributes to high-impact research at the food-environment-health interface. Her publication portfolio reveals evolving research trajectories from early climate-food connections toward contemporary explorations of alternative proteins, regenerative agriculture, and the political economy of food system transformation. Recognition Oxford Martin School Fellowship Garnett's leadership through TABLE exemplifies her commitment to creating spaces for inclusive, evidence-informed dialogue about building food systems that are sustainable, resilient, and just. Her work consistently bridges academic research and practical application, emphasizing that context-specific solutions and multi-stakeholder engagement are essential for meaningful food system transformation.
Christine Clark, MD, MSc is an attending laryngologist at Weill Cornell Medicine’s Sean Parker Institute for the Voice and Assistant Professor in the Department of Otolaryngology-Head and Neck Surgery at Weill Cornell Medical College. She earned her B.A. from the University of Pittsburgh (2011) and her M.D. from Pennsylvania State University College of Medicine (2017), followed by residency at Georgetown University Medical Center and a fellowship in Laryngology at Weill Cornell, where she also obtained a master’s degree in Clinical and Translational Science. B.A. - University of Pittsburgh (2011) M.D. - Pennsylvania State University College of Medicine (2017) Residency - Georgetown University Medical Center Fellowship - Sean Parker Institute for the Voice (Laryngology) Master’s - Clinical and Translational Science at Weill Cornell Dr. Clark specializes in evaluating and treating swallowing, voice, and airway disorders. Her research focuses on chronic cough, laryngeal hypersensitivity, and benign phonotraumatic vocal fold lesions. She has developed clinical tools like the 3D-printed injection laryngoplasty simulator and quality improvement initiatives for surgical airway management. Her clinical work and research span topics such as vocal fold hemorrhage management, pharyngeal residue quantification in dysphagia, and granuloma as markers of malignancy. Recent publications emphasize global otolaryngology capacity building and performer-specific voice injury care. Scientific awards include: Teaching awards for excellence in medical student education during residency Dr. Clark is affiliated with the Sean Parker Institute for the Voice at Weill Cornell Medicine and serves as an Assistant Professor of Otolaryngology.
Dan Lizotte is an Associate Professor jointly appointed to the Department of Computer Science in the Faculty of Science and the Department of Epidemiology and Biostatistics in the Schulich School of Medicine & Dentistry at Western University. Additional affiliations include the Schulich Interfaculty Program in Public Health and a cross-appointment to the Department of Statistics and Actuarial Sciences. Based in Middlesex College, London, Ontario, his contact email is dlizotte@uwo.ca. His research centers on machine learning and biostatistics for health decision support, with emphasis on sequential decision-making in chronic disease management where evolving patient health status and preferences inform adaptive interventions. Core contributions involve adapting reinforcement learning frameworks to model dynamic health decisions in public health and primary care settings, addressing methodological challenges in personalized medicine and risk prediction. Analysis of his publication record reveals consistent focus on healthcare applications of machine learning, particularly in chronic disease risk modeling using electronic medical records, intersectionality frameworks in public health AI, and Bayesian methods for dose personalization. His work bridges reinforcement learning with clinical decision support systems, advancing dynamic treatment regimes and statistical methodologies for evolving patient data. No scientific awards were mentioned in the provided text. The text does not specify any advisees, grant funding, or educational background details. Lizotte leads a research laboratory focused on machine learning applications in health, as evidenced by the dedicated lab site referenced in his contact information. His team likely explores intersections of statistical methodology, AI ethics, and clinical implementation for personalized health interventions.
Dr. Kenji Fujita is a Research Fellow at the Kolling Institute, University of Sydney, specializing in ageing, pharmacology, and pharmaceutical care quality. He holds a PhD, MScMed (ClinEpid), and BPharm from the University of Sydney. Previously a pharmacist in Japan, he leads international initiatives in the Pharmaceutical Care Network Europe (PCNE) and the International Pharmaceutical Federation (FIP). His work focuses on deprescribing strategies, polypharmacy, and developing quality indicators for healthcare services. Dr. Fujita’s research integrates big data analysis, statistical modeling, and machine learning to address challenges in geriatric pharmacotherapy. Current projects include validating frailty indices, evaluating deprescribing interventions in older adults, and developing NLP tools for clinical documentation analysis. He has also contributed to assessing organizational readiness for guideline implementation in community pharmacies. Awards include the 2023 Outstanding Poster Presentation Award at the IAGG Asia/Oceania Congress and 2022 Best Poster at the Japanese Society of Social Pharmacy. He has secured grants such as the 2024 electronic frailty index project and the 2021 systems-approach to medication review initiative. Dr. Fujita collaborates with global networks like J-HOP (Japan Home Visiting Pharmacy Association) and leads multidisciplinary teams across Australia and Europe. His lab focuses on translating data-driven insights into actionable clinical practices to improve medication safety and quality in ageing populations.
Nashwa Masnoon is a Postdoctoral Research Fellow in Geriatric Pharmacotherapy at the Kolling Institute, part of the Faculty of Medicine and Health at the University of Sydney. She is also a hospital pharmacist at the Royal North Shore Hospital. Her academic background includes a BPharm(Hons) and a PhD from the University of South Australia, where her doctoral work focused on identifying risks of adverse outcomes from polypharmacy in older adults with multimorbidity. Dr Masnoon’s research interests span geriatric pharmacology, deprescribing practices, pharmacoepidemiology, and quality use of medicines. Her current projects include developing stewardship programs for anticholinergic/sedative deprescribing, optimizing medication use in hospitals for older patients, and educating hospital pharmacists using the Drug Burden Index intervention bundle. She has co-supervised Honours students in 2022 and 2023, focusing on deprescribing in hospital settings and patient-reported experiences post-intervention. Research Themes: Healthy Ageing Key Approaches: Systematic reviews, clinical interventions, pharmacoepidemiological analysis Dr Masnoon has received notable awards including the 2023 FMH Showcase Travel Award, Royal North Shore Hospital Travel Fellowship (2023), and a 2017 People’s Choice Award for her 3 Minute Thesis presentation. Her work emphasizes improving medication outcomes through evidence-based deprescribing and precision medicine approaches. She is affiliated with the Australasian Pharmaceutical Science Association (APSA), International Pharmaceutical Federation (FIP), and Australian Deprescribing Network (ADeN). Her grants include the 2024 electronic frailty index project and a 2022 travel award-funded initiative.
Juliet M. Moringiello is Professor of Law and Associate Dean for Academic Affairs at Widener University - Commonwealth Law School, where she has established herself as a leading scholar in property law, electronic contracting, and blockchain technology. Her work bridges traditional legal doctrines with emerging digital economies, particularly in the areas of NFTs, crypto assets, and secured transactions. Position: Professor of Law, Associate Dean for Academic Affairs Institution: Widener University - Commonwealth Law School, Harrisburg, PA Her research interests focus on the evolving landscape of digital property, including the legal treatment of tokens, virtual assets, and blockchain-based real estate. She critically examines the Uniform Commercial Code (UCC), particularly Articles 9 and 12, in the context of technological innovation. Moringiello also explores municipal bankruptcy, consumer contracts, and the implications of automated enforcement mechanisms like smart contracts. The trends in her recent publications reflect a growing scholarly engagement with decentralized technologies. Her work analyzes how traditional legal frameworks—such as property rights, title registration, and contract formation—apply (or fail) in digital environments. She frequently collaborates with legal scholars like Christopher K. Odinet and William L. Reynolds, contributing to foundational debates on electronic assent, consumer protection, and financial regulation. Moringiello’s scholarship has been widely disseminated through major law reviews and research platforms. Her publications appear in journals such as Florida Law Review , William & Mary Law Review , Rutgers Law Review , and Yale Journal on Regulation . She has also contributed to book chapters with Cambridge University Press. She has been involved in public policy discussions, notably co-authoring commentaries on the Federal Trade Commission’s proposed ban on non-compete clauses. Her academic leadership is evident in her editorial and collaborative roles across legal academia. Moringiello has advised on issues related to data security, domain name enforcement, and the legal infrastructure of subprime mortgages. Her work on municipal receiverships and bankruptcy highlights the intersection of public trust, governance, and financial distress. Although no formal advising or grant information is listed, her extensive collaborative research suggests active engagement in scholarly networks and policy initiatives.
Dr. Lauren Cirrincione is an Associate Professor in the Department of Pharmacy at the University of Washington School of Pharmacy in Seattle, Washington. Her academic appointment is within the Department of Pharmacy, which is part of the School of Pharmacy at the University of Washington. Dr. Cirrincione earned her Doctor of Pharmacy (PharmD) degree from the University of Pittsburgh School of Pharmacy and a Master of Public Health (MPH) in epidemiology from the University of Nebraska Medical Center. She completed a clinical pharmacology fellowship in HIV at the University of Nebraska Medical Center. Dr. Cirrincione's research program addresses mechanisms of hormone-mediated drug interactions, with a primary focus on clinical, translational pharmacology in transgender medicine. Her expertise spans Infectious Diseases, Mechanisms of Drug Interactions, Pharmacokinetics-Pharmacodynamics, Transgender and Gender Diverse Research, and Translational Research. Her work examines how gender-affirming hormone therapy interacts with other medications, particularly antiretrovirals, and investigates the clinical implications of these interactions for transgender patients. She has made significant contributions to understanding estradiol concentrations in gender-affirming therapy, kidney function assessment in gender-diverse populations, and the inclusion of transgender individuals in clinical trials. Her publications demonstrate a consistent focus on improving pharmacological care for transgender and gender-diverse individuals, with recent work examining adolescent transgender medicine, psychotropic medication interactions, and self-injection experiences among transgender people on hormone therapy. Her research bridges clinical pharmacology with gender-affirming care, addressing critical gaps in evidence-based practice for this population. Dr. Cirrincione teaches PHRMCY 535: Pharmacotherapeutics V at the University of Washington School of Pharmacy. Her scientific contributions have advanced the field of transgender pharmacology, with particular emphasis on clinical applications and evidence-based approaches to medication management for transgender patients.
Thomas Grote is a Research Fellow at the University of Tübingen's Ethics and Philosophy Lab within the Cluster of Excellence 'Machine Learning: New Perspectives for Science'. His research focuses on philosophical and ethical dimensions of artificial intelligence, particularly interpretability, fairness, and reliability in medical and social contexts. He co-supervises the Carl-Zeiss-Stiftung-funded project 'Certification and Foundations of Safe Machine Learning Systems in Healthcare' and co-organizes the 'Philosophy of Science Meets Machine Learning' conference series. Research Focus Grote's interdisciplinary work bridges philosophy of science and applied AI ethics. Key areas include: Methodological foundations of AI ethics and epistemology Clinical reliability and safety of ML systems Fairness metrics in sociotechnical healthcare systems Interpretability requirements for medical AI Computational psychiatry and evolving mental health frameworks His recent publications demonstrate strong emphasis on healthcare applications, with critical analyses of reliability in foundation models, ethical paradigms for LLMs, and rethinking evaluation methodologies at the epistemology-ethics interface.
Adam C Stein is an Associate Professor in the Department of Medicine at Northwestern University's Feinberg School of Medicine, specializing in gastrointestinal disorders of the small bowel. He provides clinical care at Northwestern Memorial Hospital and Ann & Robert H. Lurie Children's Hospital of Chicago, with expertise in Crohn's disease, celiac disease, intestinal failure, and malnutrition management. Education: MD from University of Illinois, Chicago (2007) Residency in Internal Medicine at University of Chicago (2010) Fellowship in Gastroenterology at University of Chicago (2013) Fellowship in Nutrition at University of Chicago (2014) Dr. Stein's research focuses on small bowel pathologies including obscure gastrointestinal bleeding, cystic fibrosis-related GI complications, and advanced endoscopic techniques like video capsule endoscopy and double balloon enteroscopy. His clinical work emphasizes nutritional support through parenteral nutrition and tube feeding for complex malabsorption syndromes. Recent publications (2022-2024) demonstrate concentrated research on gastrointestinal manifestations in rare diseases (nephropathic cystinosis) and cystic fibrosis, with particular attention to nutritional management barriers and drug safety profiles in inflammatory bowel disease therapies. No scientific awards are listed in the current profile. Information regarding student advising and research grants is not specified in available materials, though Dr. Stein maintains active industry collaborations through consulting roles with AbbVie, Amgen, and Takeda Pharmaceuticals. As a member of the Division of Gastroenterology and Hepatology, Dr. Stein collaborates with multidisciplinary teams across Northwestern Medicine's academic hospitals, contributing to clinical committees including the ACG Training Committee (2017-2023) and editorial boards such as Current Gastroenterology Reports (2019-2023).
Professor Heiko Spallek is Head of School and Dean at the University of Sydney’s Sydney Dental School, leading the school’s integration with the Faculty of Medicine and Health. He also serves as Academic Lead for Digital Health and Health Service Informatics at the faculty level. His research focuses on advancing dental informatics, teledentistry, and evidence-based practice, while advocating for improved oral health policy and public health initiatives. He holds roles including director at Community Connections Australia and membership in the Charles Perkins Centre. Education: DMD, Dr. med. dent., MSBA(CIS), FACD, FAIDH Leadership: Oversees Sydney Dental School’s academic and clinical programs, emphasizing interprofessional education and digital health innovation. Research interests include leveraging big data and machine learning in dentistry, improving access to oral healthcare through teledentistry, and addressing systemic issues in dental education and policy. He has led projects on laser dentistry applications, dental caries prevention, and healthcare workforce regulation. Notable contributions include the OpenWide conference series, the BigMouth dental data repository, and advocacy for equitable dental funding in Australia. Grants include initiatives on oral hygiene in aged care and analysis of healthcare advertising perceptions. Media engagements highlight his role in public discourse on dental access and policy, including commentary on Australia’s dental crisis and aged care reforms. He actively promotes interdisciplinary collaboration through platforms like the Dental Informatics Online Community. Labs/Teams: Directs the Sydney Dental School’s research programs in informatics and public health, collaborating with national and international networks such as the National Dental PBRN.
Dr. Joseph Choi is a Clinical Lecturer and General Surgery Fellow at the University of Sydney's Westmead Clinical School, within the Discipline of Surgery under the Faculty of Medicine and Health. He holds academic qualifications including BSc(Adv), MBBS, MPhil, and FRACS. His clinical and research interests focus on surgical outcomes, colorectal surgery, endometriosis management, and minimally invasive techniques. Dr. Choi's research emphasizes surgical complications, anastomotic leak prediction, and emerging surgical technologies. He has contributed to over 30 peer-reviewed publications since 2011, with recent work addressing robotic surgery feasibility, Strongyloides stercoralis infections, and HER2 therapy outcomes in breast cancer. His academic profile includes collaborations with multidisciplinary teams across oncology, gastroenterology, and gynecology. No formal awards or grants are explicitly listed, though his prolific publication record reflects sustained scholarly activity.
